Goodwill and Other Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Movements in Goodwill

Movements in goodwill attributable to each reportable segment for the three months ended March 31, 2021 were as follows:

(DOLLARS IN MILLIONS)	Nourish		Health & Biosciences		Scent		Pharma Solutions		Total
Balance at December 31, 2020	$	4,859	$	—	$	734	$	—	$	5,593
Acquisitions(1)	2,839		7,291		—		1,632		11,762
Foreign exchange	(110)		(107)		(12)		(22)		(251)
Reallocation	(985)		728		257		—		—
Balance at March 31, 2021	$	6,603	$	7,912	$	979	$	1,610	$	17,104

_______________________ 

(1)Acquisitions relate to the Merger with N&B. The amount of goodwill, and allocation of goodwill among reporting units, from the Merger with the N&B Business is preliminary and may materially change in future periods as a result of purchase accounting being finalized. See Note 3 for additional information.

Schedule of Other Intangible Assets, Net

Other intangible assets, net consisted of the following amounts:

	March 31,		December 31,
(DOLLARS IN MILLIONS)	2021		2020
Asset Type
Customer relationships	$	9,397	$	2,728
Trade names & patents	453		187
Technological know-how	2,579		479
Other	30		38
Total carrying value	12,459		3,432
Accumulated Amortization
Customer relationships	(500)		(470)
Trade names & patents	(126)		(38)
Technological know-how	(154)		(168)
Other	(27)		(29)
Total accumulated amortization	(807)		(705)
Other intangible assets, net	$	11,652	$	2,727

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Amortization expense for the next five years is expected to be as follows:

(DOLLARS IN MILLIONS)	2021		2022		2023		2024		2025
Estimated future intangible amortization expense	$	608	$	807	$	807	$	807	$	805